COVID-19 in Cancer Patients

Severe acute respiratory syndrome (SARS-CoV-2) spread in whole of the world and was declared as pandemic by the WHO [world health organization]. SARS-CoV-2 has been responsible to cause more severe symptoms in immunocompromised patients. Much effort is currently being put into researching COVID-19's pathophysiology and treatment, although there are various parameters which are not very well known to us; reasons are still unknown. The purpose of the review is to encourage research into prognoses of COVID-19 infections in cancer patients, allowing for better clinical management of these patients. These researches will further help professionals to get the exact prognosis and help treat patients. These all features which will be mentioned in the article will show impact of covid on patients with various type of cancer. There are various risks associated with cancer during corona as these people are having very less immunity. Diseases which are very communicable easily infect people with cancer. There is no difference in symptoms seen in normal person and immunocompromised patients. The main motive is to help doctors in assessing prognosis and treatment.